Beyond the Scalpel: Integrating Digital Health and Artificial Intelligence to Refine Stress Urinary Incontinence Treatment Pathways

We commend Offiah et al. for their insightful study, “A Medium to Long-Term Study Comparing Stress Urinary Incontinence Procedures” [1]. Their work provides a valuable clinical benchmark comparing four surgical procedures for stress urinary incontinence (SUI), reaffirming the high efficacy of autologous fascial sling (AFS) and retropubic tape (TVT) procedures while highlighting the superior safety profile of AFS. The study's emphasis on patient-reported outcome measures (PROMs) and shared decision-making is particularly laudable. Building upon their robust findings, we wish to extend the discussion by exploring how emerging digital health and artificial intelligence (AI) technologies can further enhance patient care, personalize treatment selection, and address some of the methodological challenges inherent in long-term surgical follow-up. First, the principle of shared decision-making, a strength of the authors' institutional approach, can be significantly amplified through digital health platforms from a public health perspective. The global burden of SUI is substantial [2], yet many women do not seek care due to embarrassment or lack of awareness of treatment options. Digital health tools, such as mobile applications and telehealth services, can deliver accessible, evidence-based information and guided conservative therapies, like pelvic floor muscle training (PFMT), at scale. By empowering patients with knowledge and first-line treatment options remotely, we can create a more effective triage system. This ensures that patients proceeding to surgical consultation are better informed and appropriately selected, potentially improving postoperative satisfaction and managing healthcare resources more efficiently. This digital-first approach strengthens the foundation of the shared decision-making process that Offiah et al. rightly advocate for [3]. Second, while the study concludes that AFS is the procedure of choice, the decision between highly effective treatments like AFS and TVT remains complex and patient-specific. This is where AI offers a promising frontier [4]. Machine learning (ML) models have the potential to transcend population-level efficacy rates by generating personalized risk-benefit predictions. By integrating multidimensional data—including patient demographics, urodynamic parameters, comorbidities, pelvic floor imaging, and even genomic data—ML algorithms could predict an individual's probability of success, cure durability, and risk of specific complications (e.g., voiding dysfunction with AFS vs. mesh-related pain with TVT) for each surgical option. Such a clinical decision support tool would not replace the surgeon's expertise but would augment it, allowing for a more nuanced and data-driven conversation with the patient about which procedure truly aligns with their unique clinical profile and personal priorities [5]. Finally, the authors acknowledge the inherent challenge of long-term follow-up and the lack of validated questionnaires for certain complications, such as mesh exposure. This is a universal issue in surgical outcomes research. Digital health offers a powerful solution through remote patient monitoring and “digital phenotyping.” Instead of relying on intermittent, mailed questionnaires, which are susceptible to recall bias and low response rates, wearable sensors and smartphone apps can collect continuous or frequent real-world data. This could include objective measures like activity levels and sleep patterns [6], as well as ecological momentary assessments of symptoms (e.g., leakage episodes, pain scores) logged in real-time. This high-resolution longitudinal data can provide deeper insights into a patient's recovery trajectory, enable the early detection of late-onset complications, and offer a more accurate picture of the long-term decline in surgical efficacy noted by the authors [7]. In conclusion, the study by Offiah et al. provides a crucial foundation for contemporary management of SUI. By integrating the scalable interventions of digital health and the predictive power of AI, the medical community can build upon this evidence. The next evolution in SUI care lies in leveraging these technologies to create a more proactive, personalized, and patient-centric pathway, from initial diagnosis to long-term postoperative surveillance. Arsalan Ikram Shah: conceptualization, writing – original draft, writing – review and editing. Wenjuan Sun: conceptualization, writing – review and editing. Kunpeng Yang: conceptualization, writing – review and editing. Yong Wang: conceptualization, writing – review and editing, supervision, project administration. AI Assistance Statement: ChatGPT (developed by OpenAI) was used solely to improve the language clarity and fluency of the manuscript. The tool was not involved in the study design, data analysis, or interpretation. The authors take full responsibility for the content and integrity of the work. The authors have nothing to report. The authors declare no conflicts of interest. The authors have nothing to report.